Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Rhophylac Market Report 2025

Rhophylac Market Report 2025: Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 – By Indication (Suppression Of Rh Isoimmunization, Incompatible Transfusions, Immune Thrombocytopenic Purpura (ITP)), By Administration (Intravenous (IV), Intramuscular (IM)), By Distribution Channel (Hospitals, Clinics, Pharmacies), By End User (Pediatric, Adult, Geriatric)

Rhophylac Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Rhophylac Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Rhophylac Market Definition

Rhophylac is a human anti-D immunoglobulin used to prevent Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells. It is commonly administered during pregnancy, after childbirth, or following blood transfusions to avoid complications like hemolytic disease of the newborn.

The main types of indications in rhophylac are suppression of Rh isoimmunization, incompatible transfusions, and immune thrombocytopenic purpura (ITP). Suppression of Rh isoimmunization involves administering Rh immunoglobulin (RhIg) to a Rh-negative mother to prevent her immune system from producing antibodies against Rh-positive fetal blood cells, thus reducing the risk of complications in future pregnancies. It is administered via intravenous (IV) and intramuscular (IM) routes and distributed through various channels such as hospitals, clinics, and pharmacies. The various end users include pediatric, adult, and geriatric.

Rhophylac Market Segmentation

The rhophylac market covered in this report is segmented –

1) By Indication: Suppression Of Rh Isoimmunization; Incompatible Transfusions; Immune Thrombocytopenic Purpura (ITP)

2) By Administration: Intravenous (IV); Intramuscular (IM)

3) By Distribution Channel: Hospitals; Clinics; Pharmacies

4) By End User: Pediatric; Adult; Geriatric

Rhophylac Market Size and growth rate 2025 to 2029: Graph

Rhophylac Market Size 2025 And Growth Rate

The rhophylac market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing incidence of rh-negative blood type, rising incidence rates of rh incompatibility, increasing prevalence of autoimmune diseases, increase in the number of blood donations, and bleeding disorders.

Rhophylac Market Growth Forecast

The rhophylac market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing awareness of blood safety, government and health organization initiatives, improved healthcare infrastructure, advancements in immunoglobulin delivery, and rising transplantation procedures. Major trends in the forecast period include technological advancements in blood products, adoption of automated blood group typing technologies, technological advancements in drug formulation, and enhanced diagnosis and detection techniques.

Book your 30 minutes free consultation with our research experts

Contact Us

Rhophylac Market Driver: Rising Awareness Of Blood Safety Driving Growth In The Market

The rising awareness of blood safety is expected to propel the growth of the rhophylac market going forward. Blood safety refers to the measures and practices designed to prevent contamination and infection transmission, ensuring the safety of blood and blood products through donor screening, disease testing, proper storage, and handling. The rising awareness of blood safety can be attributed to factors such as increased public health campaigns, advancements in blood screening technologies, stricter regulatory standards, global health crises, rising incidents of bloodborne diseases, and enhanced medical training. Rhophylac helps raise awareness of blood safety by preventing Rh incompatibility in pregnant women, ensuring safe blood management, and reducing the risk of hemolytic disease of the newborn. For instance, in December 2023, according to the UK Health Security Agency, a UK-based government agency, in 2021 and 2022, the number of blood donations continued to rise compared to previous years. In 2022, 1.8 million donations were made by 950,000 donors across the UK. Moreover, in August 2023, according to the Royal College of Pathologists, a UK-based organization, blood transfusion is the most frequently performed procedure for hospitalized patients, with nearly 2 million blood components issued and transfused in England annually, costing over £300 ($390.69) million. Therefore, rising awareness of blood safety is driving the growth of the rhophylac market.

Rhophylac Market Driver: Impact Of Rising Organ Transplants On The Growth Of The Market

The growing number of organ transplants is expected to propel the growth of the rhophylac market going forward. Organ transplants refer to the medical procedure of replacing a damaged or failing organ in a patient’s body with a healthy one from a donor to save or improve the patient’s life. The growing number of organ transplants can be attributed to factors such as advancements in medical technology, improved surgical techniques, better post-transplant care, increasing organ donor awareness, and rising rates of chronic diseases like kidney failure, heart disease, and liver cirrhosis. Rhophylac is used in organ transplants to prevent immune rejection and alloimmunization by providing passive immunization with Rh immunoglobulin, reducing sensitization to foreign antigens. For instance, in January 2023, according to the United Network for Organ Sharing, a US-based non-profit organization, in 2022, the United States saw a total of 42,887 organ transplants, marking a 3.7% increase compared to 2021. Therefore, the rising number of organ transplants is driving the growth of the rhophylac market.

Rhophylac Market Driver: Rising Healthcare Expenditure Driving Growth In The Market

The increasing healthcare expenditure is expected to propel the growth of the rhophylac market going forward. Healthcare expenditure refers to the total amount spent on healthcare services and products within a specific period. The increase in healthcare expenditure is driven by factors including aging populations, advancements in medical technology, and rising demand for healthcare services. Rhophylac, a human immune globulin, helps reduce healthcare expenditure by preventing Rh incompatibility-related complications in pregnancy, thereby avoiding costly treatments for hemolytic disease of the newborn. For instance, in July 2024, according to Statistics Austria, an Austria-based federal agency, in 2023, Austria's healthcare expenditure reached $56.47 billion (€52.28 billion), accounting for 10.9% of the nation's GDP. This represents a year-on-year increase of $2.57 billion (€2.38 billion), or 4.8%, compared to 2022. Therefore, the rising healthcare expenditure is driving the growth of the rhophylac market.

Global Rhophylac Market Major Players

Major companies operating in the rhophylac market are CSL Behring AG

Regional Analysis For The Global Rhophylac Market

North America was the largest region in the rhophylac market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rhophylac market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rhophylac market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Rhophylac Market?

The rhophylac market consists of sales of injections, vials, pre-filled syringes, rh immunoglobulin products, and companion products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Rhophylac Industry?

The rhophylac market research report is one of a series of new reports from The Business Research Company that provides rhophylac market statistics, including the rhophylac industry global market size, regional shares, competitors with the rhophylac market share, detailed rhophylac market segments, market trends, and opportunities, and any further data you may need to thrive in the rhophylac industry. This rhophylac market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Rhophylac Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 Included ?
Revenue Forecast In 2034 Included ?
Growth Rate Included ?
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The rhophylac market covered in this report is segmented –
1) By Indication: Suppression Of Rh Isoimmunization; Incompatible Transfusions; Immune Thrombocytopenic Purpura (ITP)
2) By Administration: Intravenous (IV); Intramuscular (IM)
3) By Distribution Channel: Hospitals; Clinics; Pharmacies
4) By End User: Pediatric; Adult; Geriatric
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled CSL Behring AG
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Rhophylac Market Characteristics

    3. Rhophylac Market Biologic Drug Characteristics

    3.1. Molecule Type

    3.2. Route Of Administration (ROA)

    3.3. Mechanism Of Action (MOA)

    3.4. Safety And Efficacy

    4. Rhophylac Market Trends And Strategies

    5. Rhophylac Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

    6. Global Rhophylac Growth Analysis And Strategic Analysis Framework

    6.1. Global Rhophylac PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    6.2. Analysis Of End Use Industries

    6.3. Global Rhophylac Market Growth Rate Analysis

    6.4. Global Rhophylac Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

    6.5. Global Rhophylac Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

    6.6. Global Rhophylac Total Addressable Market (TAM)

    7. Global Rhophylac Pricing Analysis & Forecasts

    8. Rhophylac Market Segmentation

    8.1. Global Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Suppression Of Rh Isoimmunization

    Incompatible Transfusions

    Immune Thrombocytopenic Purpura (ITP)

    8.2. Global Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Intravenous (IV)

    Intramuscular (IM)

    8.3. Global Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Hospitals

    Clinics

    Pharmacies

    8.4. Global Rhophylac Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    Pediatric

    Adult

    Geriatric

    9. Global Rhophylac Epidemiology Of Clinical Indications

    9.1. Drug Side Effects

    9.2. Incidence And Prevalence of Clinical Indications

    10. Rhophylac Market Regional And Country Analysis

    10.1. Global Rhophylac Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    10.2. Global Rhophylac Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11. Asia-Pacific Rhophylac Market

    11.1. Asia-Pacific Rhophylac Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    11.2. Asia-Pacific Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.3. Asia-Pacific Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    11.4. Asia-Pacific Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    12. China Rhophylac Market

    12.1. China Rhophylac Market Overview

    12.2. China Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.3. China Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    12.4. China Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

    13. India Rhophylac Market

    13.1. India Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.2. India Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    13.3. India Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14. Japan Rhophylac Market

    14.1. Japan Rhophylac Market Overview

    14.2. Japan Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.3. Japan Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    14.4. Japan Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15. Australia Rhophylac Market

    15.1. Australia Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.2. Australia Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    15.3. Australia Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16. South Korea Rhophylac Market

    16.1. South Korea Rhophylac Market Overview

    16.2. South Korea Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.3. South Korea Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    16.4. South Korea Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17. Western Europe Rhophylac Market

    17.1. Western Europe Rhophylac Market Overview

    17.2. Western Europe Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.3. Western Europe Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    17.4. Western Europe Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18. UK Rhophylac Market

    18.1. UK Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.2. UK Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    18.3. UK Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19. Germany Rhophylac Market

    19.1. Germany Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.2. Germany Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    19.3. Germany Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20. France Rhophylac Market

    20.1. France Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.2. France Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    20.3. France Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21. Eastern Europe Rhophylac Market

    21.1. Eastern Europe Rhophylac Market Overview

    21.2. Eastern Europe Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.3. Eastern Europe Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    21.4. Eastern Europe Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22. North America Rhophylac Market

    22.1. North America Rhophylac Market Overview

    22.2. North America Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.3. North America Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    22.4. North America Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23. USA Rhophylac Market

    23.1. USA Rhophylac Market Overview

    23.2. USA Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.3. USA Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    23.4. USA Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24. Canada Rhophylac Market

    24.1. Canada Rhophylac Market Overview

    24.2. Canada Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.3. Canada Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    24.4. Canada Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25. South America Rhophylac Market

    25.1. South America Rhophylac Market Overview

    25.2. South America Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.3. South America Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    25.4. South America Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26. Middle East Rhophylac Market

    26.1. Middle East Rhophylac Market Overview

    26.2. Middle East Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.3. Middle East Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    26.4. Middle East Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27. Africa Rhophylac Market

    27.1. Africa Rhophylac Market Overview

    27.2. Africa Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.3. Africa Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    27.4. Africa Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

    28. Rhophylac Market Competitive Landscape And Company Profiles

    28.1. Rhophylac Market Competitive Landscape

    28.2. Rhophylac Market Company Profiles

    28.2.1. CSL Behring AG Overview, Products and Services, Strategy and Financial Analysis

    29. Global Rhophylac Market Pipeline Analysis

    29.1. High Level Clinic Trail Information

    30. Global Rhophylac Market Competitive Benchmarking And Dashboard

    31. Key Mergers And Acquisitions In The Rhophylac Market

    32. Recent Developments In The Rhophylac Market

    33. Rhophylac Market High Potential Countries, Segments and Strategies

    33.1 Rhophylac Market In 2029 - Countries Offering Most New Opportunities

    33.2 Rhophylac Market In 2029 - Segments Offering Most New Opportunities

    33.3 Rhophylac Market In 2029 - Growth Strategies

    33.3.1 Market Trend Based Strategies

    33.3.2 Competitor Strategies

    34. Appendix

    34.1. Abbreviations

    34.2. Currencies

    34.3. Historic And Forecast Inflation Rates

    34.4. Research Inquiries

    34.5. The Business Research Company

    34.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Million
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Table 3: Global Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 4: Global Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 5: Global Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 6: Global Rhophylac Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 7: Global Rhophylac Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 8: Global Rhophylac Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 9: Asia-Pacific, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 10: Asia-Pacific, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 11: Asia-Pacific, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 12: China, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 13: China, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 14: China, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 15: India, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 16: India, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 17: India, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 18: Japan, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 19: Japan, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 20: Japan, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 21: Australia, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 22: Australia, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 23: Australia, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 24: South Korea, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 25: South Korea, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 26: South Korea, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 27: Western Europe, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 28: Western Europe, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 29: Western Europe, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 30: UK, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 31: UK, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 32: UK, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 33: Germany, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 34: Germany, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 35: Germany, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 36: France, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 37: France, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 38: France, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 39: Eastern Europe, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 40: Eastern Europe, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 41: Eastern Europe, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 42: North America, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 43: North America, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 44: North America, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 45: USA, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 46: USA, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 47: USA, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 48: Canada, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 49: Canada, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 50: Canada, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 51: South America, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 52: South America, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 53: South America, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 54: Middle East, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 55: Middle East, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 56: Middle East, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 57: Africa, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 58: Africa, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 59: Africa, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Table 60: CSL Behring AG Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Million
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million
  • Figure 3: Global Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 4: Global Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 5: Global Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 6: Global Rhophylac Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 7: Global Rhophylac Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 8: Global Rhophylac Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 9: Asia-Pacific, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 10: Asia-Pacific, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 11: Asia-Pacific, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 12: China, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 13: China, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 14: China, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 15: India, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 16: India, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 17: India, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 18: Japan, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 19: Japan, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 20: Japan, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 21: Australia, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 22: Australia, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 23: Australia, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 24: South Korea, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 25: South Korea, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 26: South Korea, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 27: Western Europe, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 28: Western Europe, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 29: Western Europe, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 30: UK, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 31: UK, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 32: UK, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 33: Germany, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 34: Germany, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 35: Germany, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 36: France, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 37: France, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 38: France, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 39: Eastern Europe, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 40: Eastern Europe, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 41: Eastern Europe, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 42: North America, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 43: North America, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 44: North America, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 45: USA, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 46: USA, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 47: USA, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 48: Canada, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 49: Canada, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 50: Canada, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 51: South America, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 52: South America, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 53: South America, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 54: Middle East, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 55: Middle East, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 56: Middle East, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 57: Africa, Rhophylac Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 58: Africa, Rhophylac Market, Segmentation By Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 59: Africa, Rhophylac Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million
  • Figure 60: CSL Behring AG Financial Performance

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Read More

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

Read More

What Is The Compression Therapy Market Overview In 2022?

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the hiv drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the rituximab biosimilars market research report 2022 with industry size, share, segments and market growth

Read More

Immunity Boosting Food Products Market 2024 – By Product Source (Herbs And Species, Nuts And Seeds, Fruits And Vegetables, Dairy-Based Products, Prebiotics, Other Product Sources), By Form (Tablets, Capsules, Powder, Liquid, Other Forms), By Distribution Channel (Store-Based, Non-Store-Based), And By Region, Opportunities And Strategies – Global Forecast To 2032

View Report

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2025 – By Technique (Competitive Assay, Sandwich Assay, Multiplex Detection Assay), By Application (Infectious Disease, Pregnancy And Fertility, Toxicology, Cardiac Marker And Cholesterol Testing, Other Applications), By End-Users (Hospitals And Clinics, Diagnostic Laboratories, Home Care, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cellular Immunotherapy Global Market Report 2025 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immuno-Oncology Drugs Global Market Report 2025 – By Type (Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others), By Therapeutic Application (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application), By End-Users (Hospitals, Clinics, Ambulatory Surgical Centers, Others) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Immunosuppressants Global Market Report 2025 – By Drug Class (Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes), By Indication (Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic Tests, Other Tests) – Market Size, Trends, And Global Forecast 2025-2034

View Report

G-CSF (Granulocyte Colony Stimulating Factors) Market 2021 - By Type (Pegfilgrastim, Filgrastim, Lenograstim), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Functional Food Market 2022 - By Product Type (Bakery & Cereals, Dairy Products, Meat, Fish & Eggs, Soy Products, Fats & Oils), By Application (Sports Nutrition, Weight Management, Immunity, Digestive Health, Clinical Nutrition, Cardio Health), By Ingredients (Carotenoids, Dietary Fibers, Fatty Acids, Minerals, Prebiotics & Probiotics, Vitamins, Others), And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the Rhophylac market?

Rhophylac is a human anti-D immunoglobulin used to prevent Rh immunization in Rh-negative individuals exposed to Rh-positive red blood cells. It is commonly administered during pregnancy, after childbirth, or following blood transfusions to avoid complications like hemolytic disease of the newborn. For further insights on the Rhophylac market, request a sample here

How will the Rhophylac market drivers and restraints affect the market dynamics? What forces will shape the Rhophylac industry going forward?

The Rhophylac market major growth driver - Rising Awareness Of Blood Safety Driving Growth In The Market. For further insights on the Rhophylac market, request a sample here

What is the forecast market size or the forecast market value of the Rhophylac market?

The Rhophylac market size has grown strongly in recent years. The rhophylac market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to increasing incidence of rh-negative blood type, rising incidence rates of rh incompatibility, increasing prevalence of autoimmune diseases, increase in the number of blood donations, and bleeding disorders. The rhophylac market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to growing awareness of blood safety, government and health organization initiatives, improved healthcare infrastructure, advancements in immunoglobulin delivery, and rising transplantation procedures. Major trends in the forecast period include technological advancements in blood products, adoption of automated blood group typing technologies, technological advancements in drug formulation, and enhanced diagnosis and detection techniques. For further insights on the Rhophylac market, request a sample here

How is the Rhophylac market segmented?

The rhophylac market covered in this report is segmented –
1) By Indication: Suppression Of Rh Isoimmunization; Incompatible Transfusions; Immune Thrombocytopenic Purpura (ITP)
2) By Administration: Intravenous (IV); Intramuscular (IM)
3) By Distribution Channel: Hospitals; Clinics; Pharmacies
4) By End User: Pediatric; Adult; Geriatric For further insights on the Rhophylac market, request a sample here

Which region has the largest share of the Rhophylac market? What are the other regions covered in the report?

North America was the largest region in the rhophylac market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rhophylac market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Rhophylac market, request a sample here.

Who are the major players in the Rhophylac market?

Major companies operating in the rhophylac market are CSL Behring AG . For further insights on the Rhophylac market, request a sample here.

What are the key trends in the Rhophylac market?

Major trends in the Rhophylac market include . For further insights on the Rhophylac market, request a sample here.

What are the major opportunities in the Rhophylac market? What are the strategies for the Rhophylac market?

For detailed insights on the major opportunities and strategies in the Rhophylac market, request a sample here.

How does the Rhophylac market relate to the overall economy and other similar markets?

For detailed insights on Rhophylac's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Rhophylac industry?

For detailed insights on the mergers and acquisitions in the Rhophylac industry, request a sample here.

What are the key dynamics influencing the Rhophylac market growth? SWOT analysis of the Rhophylac market.

For detailed insights on the key dynamics influencing the Rhophylac market growth and SWOT analysis of the Rhophylac industry, request a sample here.